Cargando…
Adjusted green HPLC determination of nirmatrelvir and ritonavir in the new FDA approved co-packaged pharmaceutical dosage using supported computational calculations
The greening of analytical methods has gained interest in the quantitative analysis field to reduce environmental impact and improve safety health conditions for analysts. Nirmatrelvir plus ritonavir is a new FDA approved co-packaged medication developed for the treatment of COVID-19. The aim of thi...
Autores principales: | Imam, Mohamed S., Batubara, Afnan S., Gamal, Mohammed, Abdelazim, Ahmed H., Almrasy, Ahmed A., Ramzy, Sherif |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811874/ https://www.ncbi.nlm.nih.gov/pubmed/36599900 http://dx.doi.org/10.1038/s41598-022-26944-y |
Ejemplares similares
-
Higher sensitive selective spectrofluorometric determination of ritonavir in the presence of nirmatrelvir: application to new FDA approved co-packaged COVID-19 pharmaceutical dosage and spiked human plasma
por: Imam, Mohamed S., et al.
Publicado: (2023) -
Simultaneous green TLC determination of nirmatrelvir and ritonavir in the pharmaceutical dosage form and spiked human plasma
por: Imam, Mohamed S., et al.
Publicado: (2023) -
Green adherent spectrophotometric determination of molnupiravir based on computational calculations; application to a recently FDA-approved pharmaceutical dosage form
por: Abdelazim, Ahmed H., et al.
Publicado: (2023) -
Green fitted second derivative synchronous spectrofluorometric method for simultaneous determination of remdesivir and apixaban at Nano gram scale in the spiked human plasma
por: Batubara, Afnan S., et al.
Publicado: (2023) -
Quantitative analysis of two COVID-19 antiviral agents, favipiravir and remdesivir, in spiked human plasma using spectrophotometric methods; greenness evaluation
por: Batubara, Afnan S., et al.
Publicado: (2023)